Weight Loss
US$ 24.48
glp-1 and ulcerative colitis Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology GLP-1 Weight Loss with Ulcerative
Description
The immediate priority is to address the drug delivery challenge
The reduced food intake with amycretin administration is presumably driven by the direct action of amycretin in brain regions such as the hypothalamus and the hindbrain
If other medications dont work, nonresponders may be good candidates for weight loss surgery
Structural determinants of binding the seven-transmembrane domain of the glucagon-like peptide-1 receptor (GLP-1R)
